[1]
BarnaM., UomoI., and PastorelloM., “Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?”, JOP, vol. 14, no. 1, pp. 102-104, Jan. 2013.